Skip to content

Preserving ACTs - Text Reminders to Increase Adherence to ACT Treatment

Preserving ACTs - Text Reminders to Increase Adherence to ACT Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01722734
Acronym
PACT
Enrollment
1140
Registered
2012-11-07
Start date
2011-06-30
Completion date
2013-01-31
Last updated
2014-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Keywords

Malaria, ACTs

Brief summary

A randomized controlled trial was conducted to assess the effectiveness of text reminders sent to ACT users through an automated text messaging system short-message-system. Study hypothesis: text message reminders increase adherence

Detailed description

A randomized controlled trial was conducted to assess the effectiveness of text reminders sent to ACT users through an automated text messaging system short-message-system. Patients were enrolled at clinics and pharmacies upon receipt of ACTs and enrolled in the automated system for 3 days.

Interventions

Patients in the two treatment arms receive six short text message reminders within 60 hours of treatment initiation at 12 hour intervals to remind them to take their malaria medication as prescribed.

Sponsors

Harvard School of Public Health (HSPH)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

-subjects acquiring ACTs in Tamale, Ghana

Exclusion criteria

* subjects acquiring ACTs for non household members * subjects under the age of 18 * subjects without access to cell phones * subjects living more than 30 minutes from pickup location

Design outcomes

Primary

MeasureTime frameDescription
Self-reported Adherence to Artemisinin-combination Therapy (ACT) Treatment70 hoursPercentage of participants completing full ACT treatment regimen 70 hours after treatment initiation. Subjects were visited at home, and asked to report when each of the prescribed six doses were taken. Adherence was defined as the (self-reported) completion of all six doses.

Countries

Ghana

Participant flow

Recruitment details

Subjects were recruited at all private and public facilities distributing Artemisinin-combination Therapies (ACTs).

Pre-assignment details

Only subjects from the Tamale area with cell phones were included.

Participants by arm

ArmCount
Control
Patients in this group received only a generic malaria information message (use bed nets) at the end of the study.
554
Short Message
Patients in this arm receive six short text message reminders within 60 hours of treatment initiation at 12 hour intervals.
277
Long Message
Patients in this arm receive six long text message reminders (reminders including justification for why patients should finish medication) within 60 hours of treatment initiation at 12 hour intervals.
309
Total1,140

Baseline characteristics

CharacteristicShort MessageLong MessageControlTotal
Age, Categorical
<=18 years
105 Participants111 Participants166 Participants382 Participants
Age, Categorical
>=65 years
14 Participants32 Participants46 Participants92 Participants
Age, Categorical
Between 18 and 65 years
158 Participants166 Participants342 Participants666 Participants
Age, Continuous23 years
STANDARD_DEVIATION 17.1
23.8 years
STANDARD_DEVIATION 17.8
25.3 years
STANDARD_DEVIATION 17.7
24.3 years
STANDARD_DEVIATION 17.6
Region of Enrollment
Ghana
277 participants309 participants554 participants1140 participants
Sex: Female, Male
Female
152 Participants180 Participants302 Participants634 Participants
Sex: Female, Male
Male
125 Participants129 Participants252 Participants506 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 5540 / 2770 / 309
serious
Total, serious adverse events
0 / 5540 / 2770 / 309

Outcome results

Primary

Self-reported Adherence to Artemisinin-combination Therapy (ACT) Treatment

Percentage of participants completing full ACT treatment regimen 70 hours after treatment initiation. Subjects were visited at home, and asked to report when each of the prescribed six doses were taken. Adherence was defined as the (self-reported) completion of all six doses.

Time frame: 70 hours

Population: The number of subjects analyzed is smaller than the number of subjects enrolled due to missing data on adherence. A total of 30 observations were lost due to missing information on adherence - 16 in the control group, 9 in the short message group, and 5 in the long message group.

ArmMeasureValue (NUMBER)
ControlSelf-reported Adherence to Artemisinin-combination Therapy (ACT) Treatment61.5 percentage of participants
Short MessageSelf-reported Adherence to Artemisinin-combination Therapy (ACT) Treatment69.0 percentage of participants
Long MessageSelf-reported Adherence to Artemisinin-combination Therapy (ACT) Treatment64.1 percentage of participants

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026